These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
236 related items for PubMed ID: 12649545
1. Cholesterol crystal embolic disease in renal allografts. Scolari F, Tardanico R, Pola A, Mazzucchelli C, Maffeis R, Bonardelli S, Maiorca P, Movilli E, Sandrini S. J Nephrol; 2003; 16(1):139-43. PubMed ID: 12649545 [Abstract] [Full Text] [Related]
2. Cholesterol embolization in a renal graft. Ott U, Gerth J, Gröne HJ, Gröne E, Wolf G. Clin Transplant; 2008; 22(5):677-80. PubMed ID: 18492071 [Abstract] [Full Text] [Related]
3. Duration of end-stage renal disease and kidney transplant outcome. Goldfarb-Rumyantzev A, Hurdle JF, Scandling J, Wang Z, Baird B, Barenbaum L, Cheung AK. Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892 [Abstract] [Full Text] [Related]
7. Cholesterol embolization in renal allografts: a clinicopathologic study of 12 cases. Lai CK, Randhawa PS. Am J Surg Pathol; 2007 Apr; 31(4):536-45. PubMed ID: 17414100 [Abstract] [Full Text] [Related]
12. Effect of donor age on the outcome of living-related kidney transplantation. Naumovic R, Djukanovic L, Marinkovic J, Lezaic V. Transpl Int; 2005 Nov; 18(11):1266-74. PubMed ID: 16221157 [Abstract] [Full Text] [Related]
13. Surgical complications and renal function after kidney alone or simultaneous pancreas-kidney transplantation: a matched comparative study. Gutiérrez P, Marrero D, Hernández D, Vivancos S, Pérez-Tamajón L, Rodríguez de Vera JM, Alarcó A, González-Posada JM. Nephrol Dial Transplant; 2007 May; 22(5):1451-5. PubMed ID: 17327283 [Abstract] [Full Text] [Related]
14. Assessment of the risk of chronic allograft dysfunction after renal transplantation in a randomized cyclosporine withdrawal trial. Hazzan M, Buob D, Labalette M, Provot F, Glowacki F, Hoffmann M, Copin MC, Noel C. Transplantation; 2006 Sep 15; 82(5):657-62. PubMed ID: 16969289 [Abstract] [Full Text] [Related]
15. Outcomes of kidney transplantation from older living donors to older recipients. Gill J, Bunnapradist S, Danovitch GM, Gjertson D, Gill JS, Cecka M. Am J Kidney Dis; 2008 Sep 15; 52(3):541-52. PubMed ID: 18653267 [Abstract] [Full Text] [Related]
16. Nephron sparing surgery is a feasible and efficient treatment of T1a renal cell carcinoma in kidney transplant: a prospective series from a single center. Chambade D, Meria P, Tariel E, Vérine J, De Kerviler E, Peraldi MN, Glotz D, Desgrandchamps F, Mongiat-Artus P. J Urol; 2008 Nov 15; 180(5):2106-9. PubMed ID: 18804233 [Abstract] [Full Text] [Related]
17. Is cholesterol embolic disease an unrecognized cause of renal graft dysfunction? de Takats DL, Pollock LE, O'Donnell PJ, Snowden S, Bewick M, Scoble JE. Nephrol Dial Transplant; 1996 Jul 15; 11(7):1325-7. PubMed ID: 8672031 [No Abstract] [Full Text] [Related]
18. A case of living-related renal transplant from the donor with membranous nephropathy. Akioka K, Okamoto M, Ushigome H, Nobori S, Suzuki T, Sakai K, Sakamoto S, Urasaki K, Yanagisawa A, Fukatsu A, Yoshimura N. Clin Transplant; 2009 Aug 15; 23 Suppl 20():62-6. PubMed ID: 19594600 [Abstract] [Full Text] [Related]
20. Simultaneous bilateral native nephrectomy and living donor renal transplantation are successful for polycystic kidney disease: the University of Maryland experience. Kramer A, Sausville J, Haririan A, Bartlett S, Cooper M, Phelan M. J Urol; 2009 Feb 15; 181(2):724-8. PubMed ID: 19091353 [Abstract] [Full Text] [Related] Page: [Next] [New Search]